Mobile

Follow-up trial with no study drug prescription in diabetic patients previously included in the REGULATE trial

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-001283-22

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To document the clinical condition of patients who were included in the REGULATE trial and exposed to the investigational drugs (benfluorex or pioglitazone).

Critère d'inclusion

  • Type II Diabetes,The medical condition investigated in the REGULATE trial (CL3-00780-148) was type II diabetes. The applied CL3-00780-150 trial, REGULATE follow-up study, is thus performed in diabetic patients

Liens